SAN FRANCISCO, March 16 /PRNewswire-FirstCall/ -- Medizone International, Inc., announces a giant step forward for the AsepticSure(TM) hospital sterilization system. Edwin Marshall, Medizone’s Chief Executive Officer explained, “A week ago we announced completing the first full round of room scale trials eliminating all pathogens across the ‘Super Bug’ spectrum on stainless steel surfaces. While it may seem counterintuitive, stainless is one of the more difficult surfaces to fully sterilize when contaminated with these highly resistant bacteria. Stainless also represents an FDA standard test surface. Today, we are announcing further developments that should have tremendous commercial implications relative to hospital acceptance of AsepticSure(TM) as the new standard in providing greatly enhanced patient safety.
“Of commercial significance in a hospital setting, we are now able to greatly reduce the time required to achieve 6 log kills on hard surfaces to 30 minutes of exposure. With the charge time and destruct time for reuse of the space factored in, that translates to a room turn around time of 80 minutes, a 40 minute saving in total turn around time from our original target of 2 hours. Fabric exposure requires an additional 15 minutes to achieve the same 6 log kill rate, which represents a full turn around for a thorough cleaning of about 95 minutes for all surface materials.”
Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure(TM) to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.
Investor Relations: 415-868-0300 / web site: www.medizoneint.com
Medizone International, Inc.
